Sexual attraction existed in different cultures is controversial. Pheromones have been determined to play a role in sexual attraction between people. They influence gonadal hormone secretion, for example, follicle maturation in the ovaries in females and testosterone and sperm production in males. Research conducted by Donald G. Dutton and Arthur P. Aron in the 1970s aimed to find the relation between sexual attraction and high anxiety conditions. In doing so, 85 male participants were contacted by an attractive female interviewer at either a fear-arousing suspension bridge or a normal bridge. Conclusively, it was shown that the male participants who were asked to
Transgender hormone therapy (male-to-female) produce full progestogenic effects with oral administration. Some progestins, such as medroxyprogesterone acetate and hydroxyprogesterone caproate, are or can be used by intramuscular or subcutaneous injection instead. Almost all progestins, with the exception of dydrogesterone, have antigonadotropic effects. The main effects of hormone therapy in transgender women are feminization and demasculinization, and are as follows: Breast, nipple, and areolar development varies considerably depending on genetics, body composition, age of HRT initiation, and many other factors. Development can take a couple years to nearly a decade for some. However, many transgender women report there is often a "stall" in breast growth